Osmotica Pharmaceuticals PLC reports results for the quarter ended in September - Earnings Summary

RVL Pharmaceuticals

15/11/2021 23:38

* Osmotica Pharmaceuticals PLC  OSMT.OQ  reported a quarterly
adjusted loss of 28 cents​​ per share for the quarter ended in
September. The mean expectation of three analysts for the
quarter was for a loss of 31 cents per share.
* Revenue fell 96.2% to $2.20 million from a year ago;  analysts
expected $2.36 million. 
* Osmotica Pharmaceuticals PLC's reported EPS for the quarter
was a loss of 28 cents​.
* The mean earnings estimate of analysts had risen by about 1.6%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Osmotica Pharmaceuticals PLC shares had fallen by 33.2% this
quarter and lost 52.2% so far this year.
* The company reported a quarterly loss of $17.86 million.
* Wall Street's median 12-month price target for Osmotica
Pharmaceuticals PLC is $6.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 15 at 11:38 p.m.
 ​All figures in US dollars unless otherwise stated